Clifford J Gunthel, MD - Medicare Infectious Disease in Atlanta, GA

Clifford J Gunthel, MD is a medicare enrolled "Internal Medicine - Infectious Disease" physician in Atlanta, Georgia. He went to Emory University School Of Medicine and graduated in 1985 and has 39 years of diverse experience with area of expertise as Infectious Disease. He is a member of the group practice Emory Medical Care Foundation Inc and his current practice location is 1365 Clifton Rd, Bldg A, Atlanta, Georgia. You can reach out to his office (for appointments etc.) via phone at (404) 778-7777.

Clifford J Gunthel is licensed to practice in Georgia (license number 031011) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1609961184.

Contact Information

Clifford J Gunthel, MD
1365 Clifton Rd, Bldg A,
Atlanta, GA 30322
(404) 778-7777
Not Available



Physician's Profile

Full NameClifford J Gunthel
GenderMale
SpecialityInfectious Disease
Experience39 Years
Location1365 Clifton Rd, Atlanta, Georgia
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Clifford J Gunthel attended and graduated from Emory University School Of Medicine in 1985
  NPI Data:
  • NPI Number: 1609961184
  • Provider Enumeration Date: 10/03/2006
  • Last Update Date: 07/08/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 5890811236
  • Enrollment ID: I20100923000328

Medical Identifiers

Medical identifiers for Clifford J Gunthel such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1609961184NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RI0200XInternal Medicine - Infectious Disease 031011 (Georgia)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Grady Memorial HospitalAtlanta, GAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Emory Medical Care Foundation Inc4981501814801

News Archive

New study suggests re-evaluation of long-held method to predict effectiveness of seasonal influenza vaccine

The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests. Currently, seasonal flu vaccines are designed to induce high levels of protective antibodies against hemagglutinin (HA), a protein found on the surface of the influenza virus that enables the virus to enter a human cell and initiate infection.

Targacept commences TC-5619 Phase 2 study of cognitive dysfunction in schizophrenia

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR TherapeuticsTM, today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in cognitive dysfunction in schizophrenia.

Melanomas mostly from from new spots rather than existing ones

According to a new study appearing this week in the Journal of the American Academy of Dermatology, melanomas do not grow from existing moles and skin growths, but from new ones. Therefore it is vital that people keep a careful eye for new growths over their skin in order to detect early stages of melanomas.

LSUHSC: Differences in drug metabolism can lead to differences in the effectiveness of candidate drug

Research led by Wayne L. Backes, PhD, Professor of Pharmacology and Associate Dean for Research at LSU Health Sciences Center New Orleans School of Medicine, has found that drug metabolism depends not only upon which enzymes are present in an individual, but also how they interact, and that can be the difference in whether a drug is safely eliminated from the body or is converted into a toxic or carcinogenic byproduct.

Combination therapy does not change safety and efficacy relationship of TORISEL for advanced RCC

Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Clifford J Gunthel allows following entities to bill medicare on his behalf.
Entity NameEmory Medical Care Foundation Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063452381
PECOS PAC ID: 4981501814
Enrollment ID: O20031217000968

News Archive

New study suggests re-evaluation of long-held method to predict effectiveness of seasonal influenza vaccine

The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests. Currently, seasonal flu vaccines are designed to induce high levels of protective antibodies against hemagglutinin (HA), a protein found on the surface of the influenza virus that enables the virus to enter a human cell and initiate infection.

Targacept commences TC-5619 Phase 2 study of cognitive dysfunction in schizophrenia

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR TherapeuticsTM, today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in cognitive dysfunction in schizophrenia.

Melanomas mostly from from new spots rather than existing ones

According to a new study appearing this week in the Journal of the American Academy of Dermatology, melanomas do not grow from existing moles and skin growths, but from new ones. Therefore it is vital that people keep a careful eye for new growths over their skin in order to detect early stages of melanomas.

LSUHSC: Differences in drug metabolism can lead to differences in the effectiveness of candidate drug

Research led by Wayne L. Backes, PhD, Professor of Pharmacology and Associate Dean for Research at LSU Health Sciences Center New Orleans School of Medicine, has found that drug metabolism depends not only upon which enzymes are present in an individual, but also how they interact, and that can be the difference in whether a drug is safely eliminated from the body or is converted into a toxic or carcinogenic byproduct.

Combination therapy does not change safety and efficacy relationship of TORISEL for advanced RCC

Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Clifford J Gunthel is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Clifford J Gunthel, MD
1365 Clifton Rd, Bldg A,
Atlanta, GA 30322

Ph: (404) 778-7777
Clifford J Gunthel, MD
1365 Clifton Rd, Bldg A,
Atlanta, GA 30322

Ph: (404) 778-7777

News Archive

New study suggests re-evaluation of long-held method to predict effectiveness of seasonal influenza vaccine

The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests. Currently, seasonal flu vaccines are designed to induce high levels of protective antibodies against hemagglutinin (HA), a protein found on the surface of the influenza virus that enables the virus to enter a human cell and initiate infection.

Targacept commences TC-5619 Phase 2 study of cognitive dysfunction in schizophrenia

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR TherapeuticsTM, today announced that it has initiated a Phase 2 clinical proof of concept trial of TC-5619 in cognitive dysfunction in schizophrenia.

Melanomas mostly from from new spots rather than existing ones

According to a new study appearing this week in the Journal of the American Academy of Dermatology, melanomas do not grow from existing moles and skin growths, but from new ones. Therefore it is vital that people keep a careful eye for new growths over their skin in order to detect early stages of melanomas.

LSUHSC: Differences in drug metabolism can lead to differences in the effectiveness of candidate drug

Research led by Wayne L. Backes, PhD, Professor of Pharmacology and Associate Dean for Research at LSU Health Sciences Center New Orleans School of Medicine, has found that drug metabolism depends not only upon which enzymes are present in an individual, but also how they interact, and that can be the difference in whether a drug is safely eliminated from the body or is converted into a toxic or carcinogenic byproduct.

Combination therapy does not change safety and efficacy relationship of TORISEL for advanced RCC

Pfizer Inc. announced that the Phase 3 INTORACT trial (B1771006), evaluating the combination of bevacizumab plus TORISEL (temsirolimus) compared with bevacizumab plus interferon-alfa-2a (IFN-α-2a) in the first-line treatment of patients with advanced renal cell carcinoma (RCC) across risk groups, did not meet its primary endpoint of superiority in extending progression free survival (PFS) in the study population.

Read more News

› Verified 8 days ago


Internal Medicine Doctors in Atlanta, GA

Khadeja Jamilia Johnson, M.D.
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1800 Howell Mill Rd Nw Ste 275, Atlanta, GA 30318
Phone: 404-756-1290    
Dr. Matthew J. Wilson, M.D.
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 755 Mt Vernon Hwy, Suite 530, Atlanta, GA 30328
Phone: 404-252-7970    Fax: 404-250-0553
Kajal Patel, M.D, M.P.H
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1525 Clifton Rd Ne, Atlanta, GA 30322
Phone: 404-778-2700    
Dr. Earl Stewart Jr., M.D.
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 2850 Paces Ferry Rd Se Ste 460, Atlanta, GA 30339
Phone: 678-556-4950    
Mary E. Bergh, MD
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 980 Johnson Ferry Rd Ste 520, Atlanta, GA 30342
Phone: 404-303-3320    Fax: 404-303-3464
John J Doran, M.D.
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1365 Clifton Rd Ne Bldg A, The Emory Clinic - Nephrology, Atlanta, GA 30322
Phone: 404-778-5380    
Frank A Anania, M.D.
Infectious Disease
Medicare: Not Enrolled in Medicare
Practice Location: 1365 Clifton Rd Ne Ste B1266, The Emory Clinic - Gastroenterology, Atlanta, GA 30322
Phone: 404-778-3184    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.